日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens

通过阻断膜抗原的蛋白酶体降解来提高CAR T细胞的疗效

Rieger, Leonie; Irlinger, Kilian; Füchsl, Franziska; Tietje, Marlene; Purcarea, Anna; Barbian, Nicolas; Faber, Melanie; Vogelsang, Carolin; Pfeuffer, Lisa; Stotz, Sonja; Karpiuk, Oleksandra; Schulze, Tobias; Augsburger, Abirami; Glaisner, Nadine; Konetzki, Verena; Friedel, Sabrina; Besse, Andrej; Besse, Lenka; Driessen, Christoph; Buchner, Maike; Schwamborn, Kristina; Steiger, Katja; Giansanti, Piero; Theurich, Sebastian; Waldschmidt, Johannes; Kortüm, K Martin; Hudecek, Michael; Einsele, Hermann; Högner, Marion; Kuster, Bernhard; Krackhardt, Angela M; Hecker, Judith S; Bassermann, Florian

Targeting proteostasis in multiple myeloma through inhibition of LTK

通过抑制LTK靶向多发性骨髓瘤中的蛋白质稳态

Thea Kristin Våtsveen ,Mariaserena Giliberto ,Valgerdur Bjornsdottir ,Federica Centonze ,Andrej Besse ,Yannick Frey ,Sigrid S Skånland ,Anders Tveita ,Amin Alirezaylavasani ,John Franklin Imbery ,Kristine Misund ,Veronika Reiterer ,Muhammad Zahoor ,Christoph Driessen ,Lenka Besse ,Kjetil Tasken ,Fredrik H Schjesvold ,Hesso Farhan # ,Ludvig A Munthe #

Carfilzomib-specific proteasome β5/β2 inhibition drives cardiotoxicity via remodeling of protein homeostasis and the renin-angiotensin-system

卡非佐米特异性抑制蛋白酶体β5/β2通过重塑蛋白质稳态和肾素-血管紧张素系统而导致心脏毒性。

Max Mendez-Lopez ,Andrej Besse ,Christian Zuppinger ,Christian Perez-Shibayama ,Cristina Gil-Cruz ,Bogdan I Florea ,Angelina De Martin ,Mechthild Lütge ,Deborah Beckerova ,Simon Klimovic ,Xiang Zhou ,Leo Rasche ,Jan Pribyl ,Vladimir Rotrekl ,Burkhard Ludewig ,Herman S Overkleeft ,Lenka Besse ,Christoph Driessen

HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer

HIV 蛋白酶抑制剂增强卡非佐米在三阴性乳腺癌中的活性

Andrej Besse, Lenka Sedlarikova, Lorina Buechler, Marianne Kraus, Chieh-Hsiang Yang, Nicol Strakova, Karel Soucek, Jiri Navratil, Marek Svoboda, Alana L Welm, Markus Joerger, Christoph Driessen, Lenka Besse

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma

卡非佐米与奈非那韦联合治疗非小细胞肺癌的细胞毒活性优于硼替佐米/奈非那韦联合治疗

Lenka Besse, Marianne Kraus, Andrej Besse, Christoph Driessen, Ignazio Tarantino

Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma

局部晚期基底细胞癌对 Vismodegib 的内在耐药性发生率和基因组学方面

Andrey A Yurchenko #, Oltin T Pop #, Meriem Ighilahriz #, Ismael Padioleau, Fatemeh Rajabi, Hayley J Sharpe, Nicolas Poulalhon, Brigitte Dreno, Amir Khammari, Marc Delord, Antonio Alberti, Nadem Soufir, Maxime Battistella, Samia Mourah, Fanny Bouquet, Ariel Savina, Andrej Besse, Max Mendez-Lopez, Fl

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors

慢性淋巴细胞白血病中的免疫蛋白酶体活性作为免疫蛋白酶体选择性抑制剂的靶点

Andrej Besse, Marianne Kraus, Max Mendez-Lopez, Elmer Maurits, Herman S Overkleeft, Christoph Driessen, Lenka Besse

Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment

病毒载体介导的成纤维细胞肿瘤基质重编程可维持黑色素瘤的治愈性治疗

Sandra S Ring, Jovana Cupovic, Lucas Onder, Mechthild Lütge, Christian Perez-Shibayama, Cristina Gil-Cruz, Elke Scandella, Angelina De Martin, Urs Mörbe, Fabienne Hartmann, Robert Wenger, Matthias Spiegl, Andrej Besse, Weldy V Bonilla, Felix Stemeseder, Sarah Schmidt, Klaus K Orlinger, Philippe Kreb

Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma

使用 HIV 蛋白酶抑制剂奈非那韦治疗可确定膜脂质组成和流动性是晚期多发性骨髓瘤的治疗靶点

Lenka Besse #, Andrej Besse #, Sara C Stolze, Amin Sobh, Esther A Zaal, Alwin J van der Ham, Mario Ruiz, Santosh Phuyal, Lorina Büchler, Marc Sathianathan, Bogdan I Florea, Jan Borén, Marcus Ståhlman, Julia Huber, Arnold Bolomsky, Heinz Ludwig, J Thomas Hannich, Alex Loguinov, Bart Everts, Celia R B

Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells

新型肽类药物结合物美氟芬可有效消灭硼替佐米耐药多发性骨髓瘤细胞,包括肿瘤起始骨髓瘤祖细胞

Konstantin Byrgazov, Andrej Besse, Marianne Kraus, Ana Slipicevic, Fredrik Lehmann, Christoph Driessen, Lenka Besse